Briefing
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma.
In 171 people with early-stage lung cancer from TRACERx, NeXT Personal detected preoperative ctDNA in 81% of those with lung adenocarcinoma.
- Design: Evidence level 2
- Assay: NeXT Personal
Nature MedicinePubMed 39806071DOI 10.1038/s41591-024-03216-y